

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.47038318 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.47038318 |
| 3 | negative T cell selection (GO:0043383) | 5.23364316 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.89587774 |
| 5 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.84007119 |
| 6 | negative thymic T cell selection (GO:0045060) | 4.78704257 |
| 7 | positive T cell selection (GO:0043368) | 4.28152178 |
| 8 | activated T cell proliferation (GO:0050798) | 4.16647583 |
| 9 | response to interleukin-15 (GO:0070672) | 4.16573985 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 4.15491401 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.11777383 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06086564 |
| 13 | tolerance induction (GO:0002507) | 4.04814822 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.03227907 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.96981304 |
| 16 | establishment of skin barrier (GO:0061436) | 3.92341111 |
| 17 | keratinization (GO:0031424) | 3.87234769 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.78623820 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.77452942 |
| 20 | positive regulation of granulocyte differentiation (GO:0030854) | 3.74844301 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70006402 |
| 22 | T cell selection (GO:0045058) | 3.61254489 |
| 23 | negative regulation of T cell mediated immunity (GO:0002710) | 3.60945056 |
| 24 | cerebellar granule cell differentiation (GO:0021707) | 3.59787655 |
| 25 | gamma-aminobutyric acid transport (GO:0015812) | 3.54891485 |
| 26 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.48116075 |
| 27 | thymic T cell selection (GO:0045061) | 3.34350679 |
| 28 | interferon-gamma production (GO:0032609) | 3.34072162 |
| 29 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.32413913 |
| 30 | * alpha-beta T cell differentiation (GO:0046632) | 3.30887380 |
| 31 | T cell migration (GO:0072678) | 3.29551152 |
| 32 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.26034714 |
| 33 | regulation of regulatory T cell differentiation (GO:0045589) | 3.24227341 |
| 34 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.24199619 |
| 35 | sodium ion export (GO:0071436) | 3.23091616 |
| 36 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.22732624 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.20804767 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.12761397 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.08590015 |
| 40 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08327652 |
| 41 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08327652 |
| 42 | * CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.05170287 |
| 43 | * T-helper cell differentiation (GO:0042093) | 3.05170287 |
| 44 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.03587957 |
| 45 | neurotransmitter secretion (GO:0007269) | 3.03135001 |
| 46 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.01825142 |
| 47 | detection of light stimulus involved in visual perception (GO:0050908) | 3.01825142 |
| 48 | leukocyte aggregation (GO:0070486) | 3.01570324 |
| 49 | neuronal action potential propagation (GO:0019227) | 3.01357192 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.01154444 |
| 51 | positive thymic T cell selection (GO:0045059) | 3.00705426 |
| 52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.99845033 |
| 53 | retinal cone cell development (GO:0046549) | 2.98412077 |
| 54 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.98087334 |
| 55 | regulation of energy homeostasis (GO:2000505) | 2.94467777 |
| 56 | glutamate secretion (GO:0014047) | 2.93656861 |
| 57 | negative regulation of adaptive immune response (GO:0002820) | 2.91363935 |
| 58 | regulation of water loss via skin (GO:0033561) | 2.89828642 |
| 59 | * T cell differentiation involved in immune response (GO:0002292) | 2.88871990 |
| 60 | * alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.88871990 |
| 61 | * alpha-beta T cell activation involved in immune response (GO:0002287) | 2.88871990 |
| 62 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.88672797 |
| 63 | synaptic vesicle exocytosis (GO:0016079) | 2.88575211 |
| 64 | * alpha-beta T cell activation (GO:0046631) | 2.85030060 |
| 65 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.81536936 |
| 66 | vocalization behavior (GO:0071625) | 2.81473870 |
| 67 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.80874295 |
| 68 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80785090 |
| 69 | positive regulation of tolerance induction (GO:0002645) | 2.80218018 |
| 70 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.78394201 |
| 71 | protein K11-linked deubiquitination (GO:0035871) | 2.76785098 |
| 72 | glutamate receptor signaling pathway (GO:0007215) | 2.76712098 |
| 73 | * CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.76316920 |
| 74 | L-phenylalanine catabolic process (GO:0006559) | 2.75853742 |
| 75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.75853742 |
| 76 | T cell receptor signaling pathway (GO:0050852) | 2.75054764 |
| 77 | cellular response to ethanol (GO:0071361) | 2.73779765 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.73014669 |
| 79 | glutamate metabolic process (GO:0006536) | 2.72505005 |
| 80 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.71457673 |
| 81 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.71017864 |
| 82 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.70819916 |
| 83 | response to pheromone (GO:0019236) | 2.69586332 |
| 84 | regulation of germinal center formation (GO:0002634) | 2.69485175 |
| 85 | regulation of T cell tolerance induction (GO:0002664) | 2.68818353 |
| 86 | histone H3-K36 demethylation (GO:0070544) | 2.67618390 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.63830299 |
| 88 | potassium ion homeostasis (GO:0055075) | 2.60521315 |
| 89 | protein targeting to Golgi (GO:0000042) | 2.56858038 |
| 90 | locomotory exploration behavior (GO:0035641) | 2.56372386 |
| 91 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.55522911 |
| 92 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.55522911 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.55454018 |
| 94 | negative regulation of protein oligomerization (GO:0032460) | 2.54813687 |
| 95 | cellular sodium ion homeostasis (GO:0006883) | 2.54752508 |
| 96 | retinal rod cell development (GO:0046548) | 2.54430345 |
| 97 | * T cell differentiation (GO:0030217) | 2.54415168 |
| 98 | keratinocyte development (GO:0003334) | 2.52232995 |
| 99 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.51217632 |
| 100 | positive regulation of muscle hypertrophy (GO:0014742) | 2.49852005 |
| 101 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.49852005 |
| 102 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.49452302 |
| 103 | positive regulation of DNA recombination (GO:0045911) | 2.48907426 |
| 104 | neurotransmitter transport (GO:0006836) | 2.48809896 |
| 105 | synaptic vesicle maturation (GO:0016188) | 2.48675382 |
| 106 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.48193922 |
| 107 | histone H3-K4 trimethylation (GO:0080182) | 2.48109890 |
| 108 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.47687372 |
| 109 | glucocorticoid metabolic process (GO:0008211) | 2.47574613 |
| 110 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.46995357 |
| 111 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.46962982 |
| 112 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.46187683 |
| 113 | Peyers patch development (GO:0048541) | 2.44240571 |
| 114 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.44240571 |
| 115 | positive regulation of isotype switching (GO:0045830) | 2.43063778 |
| 116 | response to histamine (GO:0034776) | 2.42841855 |
| 117 | regulation of memory T cell differentiation (GO:0043380) | 2.42036898 |
| 118 | establishment of protein localization to Golgi (GO:0072600) | 2.41981559 |
| 119 | potassium ion import (GO:0010107) | 2.41358955 |
| 120 | * cerebellar Purkinje cell differentiation (GO:0021702) | 2.40951923 |
| 121 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.40330488 |
| 122 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.40098947 |
| 123 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.39753581 |
| 124 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.39603157 |
| 125 | L-phenylalanine metabolic process (GO:0006558) | 2.39603157 |
| 126 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.39430226 |
| 127 | lymph node development (GO:0048535) | 2.39326985 |
| 128 | dicarboxylic acid catabolic process (GO:0043649) | 2.39156794 |
| 129 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.38934863 |
| 130 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.38675434 |
| 131 | regulation of cell killing (GO:0031341) | 2.38377277 |
| 132 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.37794756 |
| 133 | regulation of bile acid biosynthetic process (GO:0070857) | 2.35766517 |
| 134 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.35393884 |
| 135 | T cell mediated immunity (GO:0002456) | 2.34754327 |
| 136 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.33475682 |
| 137 | regulation of tolerance induction (GO:0002643) | 2.32868130 |
| 138 | photoreceptor cell development (GO:0042461) | 2.32786946 |
| 139 | desmosome organization (GO:0002934) | 2.32422143 |
| 140 | eye photoreceptor cell development (GO:0042462) | 2.32238276 |
| 141 | cellular response to epinephrine stimulus (GO:0071872) | 2.31744312 |
| 142 | regulation of synaptic vesicle transport (GO:1902803) | 2.31446853 |
| 143 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.31242449 |
| 144 | regulation of calcium-mediated signaling (GO:0050848) | 2.31002006 |
| 145 | behavioral response to cocaine (GO:0048148) | 2.30233236 |
| 146 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.30072334 |
| 147 | regulation of granulocyte differentiation (GO:0030852) | 2.29548822 |
| 148 | regulation of fibroblast apoptotic process (GO:2000269) | 2.29145975 |
| 149 | positive regulation of cell killing (GO:0031343) | 2.28954905 |
| 150 | succinate metabolic process (GO:0006105) | 2.28730625 |
| 151 | RNA destabilization (GO:0050779) | 2.28659356 |
| 152 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.28100709 |
| 153 | protein carboxylation (GO:0018214) | 2.28100709 |
| 154 | regulation of neurotransmitter levels (GO:0001505) | 2.27910365 |
| 155 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.27680365 |
| 156 | * CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.27509578 |
| 157 | positive regulation of humoral immune response (GO:0002922) | 2.27416503 |
| 158 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.26813602 |
| 159 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.26236081 |
| 160 | phospholipid efflux (GO:0033700) | 2.26235225 |
| 161 | * cell differentiation in hindbrain (GO:0021533) | 2.25510490 |
| 162 | long term synaptic depression (GO:0060292) | 2.25416013 |
| 163 | aromatic amino acid family catabolic process (GO:0009074) | 2.25234003 |
| 164 | neuron-neuron synaptic transmission (GO:0007270) | 2.25022085 |
| 165 | rhodopsin mediated signaling pathway (GO:0016056) | 2.22922658 |
| 166 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.21333576 |
| 167 | protein localization to synapse (GO:0035418) | 2.20645311 |
| 168 | synaptic transmission, glutamatergic (GO:0035249) | 2.18821209 |
| 169 | relaxation of cardiac muscle (GO:0055119) | 2.18516420 |
| 170 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.17326708 |
| 171 | high-density lipoprotein particle remodeling (GO:0034375) | 2.14728169 |
| 172 | bile acid biosynthetic process (GO:0006699) | 2.14076866 |
| 173 | regulation of activation of Janus kinase activity (GO:0010533) | 2.13339608 |
| 174 | negative regulation of protein activation cascade (GO:2000258) | 2.12616493 |
| 175 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.11549904 |
| 176 | mating behavior (GO:0007617) | 2.09897834 |
| 177 | plasma lipoprotein particle assembly (GO:0034377) | 2.09667509 |
| 178 | alpha-linolenic acid metabolic process (GO:0036109) | 2.08280878 |
| 179 | regulation of ARF protein signal transduction (GO:0032012) | 2.07501699 |
| 180 | negative regulation of lipase activity (GO:0060192) | 2.07191705 |
| 181 | regulation of vesicle fusion (GO:0031338) | 2.06549830 |
| 182 | regulation of protein activation cascade (GO:2000257) | 2.05850215 |
| 183 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.05220693 |
| 184 | long-term memory (GO:0007616) | 2.05009690 |
| 185 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.04789011 |
| 186 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.03771215 |
| 187 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.03221394 |
| 188 | regulation of postsynaptic membrane potential (GO:0060078) | 2.02893510 |
| 189 | long-term synaptic potentiation (GO:0060291) | 2.02666886 |
| 190 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.02261326 |
| 191 | protein-chromophore linkage (GO:0018298) | 2.01598319 |
| 192 | neuromuscular process controlling posture (GO:0050884) | 2.01531582 |
| 193 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.01334727 |
| 194 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.00941579 |
| 195 | linoleic acid metabolic process (GO:0043651) | 2.00564311 |
| 196 | detection of calcium ion (GO:0005513) | 1.99644190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.78911892 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50186529 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.36169159 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30380957 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.25486869 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.21722505 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.17620076 |
| 8 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.05607940 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.05553074 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.04923414 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.03014441 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.92756141 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88436170 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87803940 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87362388 |
| 16 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.83412311 |
| 17 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.83412311 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.83283278 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81619342 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.81484528 |
| 21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78949840 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.78817005 |
| 23 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.77665060 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76339764 |
| 25 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.74230295 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72847935 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72481764 |
| 28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70806123 |
| 29 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68589020 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67439880 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64761696 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.62511293 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61473163 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56571377 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53733209 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.53617424 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53573336 |
| 38 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.52264719 |
| 39 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51126356 |
| 40 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.49263013 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48715205 |
| 42 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.47840725 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47767425 |
| 44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45721249 |
| 45 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45113060 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40126031 |
| 47 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39098744 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36434531 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35499924 |
| 50 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.35208674 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35176680 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33029472 |
| 53 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.31989164 |
| 54 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31017732 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30068892 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29590906 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29264958 |
| 58 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28101574 |
| 59 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27716959 |
| 60 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27712934 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27233599 |
| 62 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.25877463 |
| 63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25292074 |
| 64 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25057480 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24097749 |
| 66 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22351798 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22301173 |
| 68 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21386069 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21142100 |
| 70 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20619039 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19868750 |
| 72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18881891 |
| 73 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.17168785 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17105488 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16578870 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16245042 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13800769 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13797855 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13755501 |
| 80 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13716328 |
| 81 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13694566 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13365487 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10758072 |
| 84 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09060093 |
| 85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08739798 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08326244 |
| 87 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.08096739 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07838341 |
| 89 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07796863 |
| 90 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07566381 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06756736 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06756736 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 1.05938810 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05816083 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05650480 |
| 96 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.05555202 |
| 97 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.04232578 |
| 98 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.04180480 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04173856 |
| 100 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03826058 |
| 101 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02831810 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02828064 |
| 103 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02101106 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01301771 |
| 105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00941045 |
| 106 | * AR_19668381_ChIP-Seq_PC3_Human | 1.00738136 |
| 107 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00666895 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99852664 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99467621 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98157485 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97926166 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97693256 |
| 113 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96917354 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96875685 |
| 115 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95841234 |
| 116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95204175 |
| 117 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.95150010 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95149353 |
| 119 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94524464 |
| 120 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94043975 |
| 121 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93730692 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93255225 |
| 123 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.92798102 |
| 124 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92665791 |
| 125 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.92414174 |
| 126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92090547 |
| 127 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91393937 |
| 128 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90514813 |
| 129 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.90200405 |
| 130 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.90196359 |
| 131 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90168028 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89580614 |
| 133 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.89460367 |
| 134 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88939624 |
| 135 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88741404 |
| 136 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88075535 |
| 137 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88059080 |
| 138 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87785992 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87338231 |
| 140 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87266126 |
| 141 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87113870 |
| 142 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.85626066 |
| 143 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.84717575 |
| 144 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84689272 |
| 145 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84236921 |
| 146 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83517276 |
| 147 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82476637 |
| 148 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.81860257 |
| 149 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81774267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.24770788 |
| 2 | MP0005671_abnormal_response_to | 3.68593011 |
| 3 | MP0005551_abnormal_eye_electrophysiolog | 3.37448722 |
| 4 | MP0009046_muscle_twitch | 3.01878622 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.95656429 |
| 6 | MP0005365_abnormal_bile_salt | 2.79401831 |
| 7 | MP0005360_urolithiasis | 2.72931603 |
| 8 | MP0006082_CNS_inflammation | 2.65189751 |
| 9 | MP0003724_increased_susceptibility_to | 2.58466125 |
| 10 | MP0001501_abnormal_sleep_pattern | 2.47707753 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.46008400 |
| 12 | MP0003011_delayed_dark_adaptation | 2.43288158 |
| 13 | MP0001502_abnormal_circadian_rhythm | 2.43086397 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.36629493 |
| 15 | MP0003880_abnormal_central_pattern | 2.36283465 |
| 16 | MP0001873_stomach_inflammation | 2.30937767 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.30915739 |
| 18 | * MP0001800_abnormal_humoral_immune | 2.29268767 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.28012469 |
| 20 | * MP0003635_abnormal_synaptic_transmissio | 2.25965259 |
| 21 | MP0002090_abnormal_vision | 2.22717784 |
| 22 | MP0009745_abnormal_behavioral_response | 2.10678642 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.05227676 |
| 24 | MP0002796_impaired_skin_barrier | 2.05053883 |
| 25 | MP0002064_seizures | 2.04874072 |
| 26 | MP0005423_abnormal_somatic_nervous | 2.02416402 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.90347580 |
| 28 | MP0006072_abnormal_retinal_apoptosis | 1.88747306 |
| 29 | MP0002272_abnormal_nervous_system | 1.87144819 |
| 30 | MP0000685_abnormal_immune_system | 1.85945416 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.85408693 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.84546997 |
| 33 | MP0002254_reproductive_system_inflammat | 1.78950397 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.77500259 |
| 35 | * MP0002723_abnormal_immune_serum | 1.72491113 |
| 36 | MP0003252_abnormal_bile_duct | 1.70998767 |
| 37 | MP0003436_decreased_susceptibility_to | 1.67668056 |
| 38 | MP0005253_abnormal_eye_physiology | 1.66938428 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.66210085 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.65275414 |
| 41 | * MP0010329_abnormal_lipoprotein_level | 1.65033725 |
| 42 | * MP0001790_abnormal_immune_system | 1.64471653 |
| 43 | * MP0005387_immune_system_phenotype | 1.64471653 |
| 44 | MP0002933_joint_inflammation | 1.61481582 |
| 45 | MP0001486_abnormal_startle_reflex | 1.60526631 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.60408220 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.60137008 |
| 48 | * MP0002420_abnormal_adaptive_immunity | 1.59039882 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.58565531 |
| 50 | MP0009785_altered_susceptibility_to | 1.56369033 |
| 51 | * MP0001819_abnormal_immune_cell | 1.54674091 |
| 52 | * MP0002063_abnormal_learning/memory/cond | 1.53227382 |
| 53 | MP0002572_abnormal_emotion/affect_behav | 1.51147049 |
| 54 | * MP0008569_lethality_at_weaning | 1.50377677 |
| 55 | MP0004270_analgesia | 1.50163648 |
| 56 | MP0003329_amyloid_beta_deposits | 1.43625528 |
| 57 | MP0001968_abnormal_touch/_nociception | 1.41286907 |
| 58 | * MP0002067_abnormal_sensory_capabilities | 1.40894948 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 1.40574008 |
| 60 | MP0003866_abnormal_defecation | 1.40347254 |
| 61 | MP0005025_abnormal_response_to | 1.39901616 |
| 62 | MP0003646_muscle_fatigue | 1.37494156 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.37127398 |
| 64 | * MP0000703_abnormal_thymus_morphology | 1.33617688 |
| 65 | * MP0001984_abnormal_olfaction | 1.33279304 |
| 66 | * MP0002452_abnormal_antigen_presenting | 1.33185547 |
| 67 | MP0005083_abnormal_biliary_tract | 1.28392375 |
| 68 | * MP0002405_respiratory_system_inflammati | 1.27348696 |
| 69 | MP0003195_calcinosis | 1.25730610 |
| 70 | MP0004885_abnormal_endolymph | 1.25646162 |
| 71 | MP0002734_abnormal_mechanical_nocicepti | 1.25131453 |
| 72 | MP0004381_abnormal_hair_follicle | 1.21201637 |
| 73 | MP0002009_preneoplasia | 1.21048457 |
| 74 | MP0004883_abnormal_blood_vessel | 1.20354519 |
| 75 | MP0002398_abnormal_bone_marrow | 1.20287693 |
| 76 | MP0000372_irregular_coat_pigmentation | 1.20207357 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 1.19310386 |
| 78 | MP0003868_abnormal_feces_composition | 1.19168690 |
| 79 | MP0001348_abnormal_lacrimal_gland | 1.18758819 |
| 80 | MP0000716_abnormal_immune_system | 1.17323477 |
| 81 | MP0001986_abnormal_taste_sensitivity | 1.15345839 |
| 82 | MP0001188_hyperpigmentation | 1.14931507 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.14877225 |
| 84 | MP0002638_abnormal_pupillary_reflex | 1.12691505 |
| 85 | MP0005174_abnormal_tail_pigmentation | 1.12631725 |
| 86 | MP0002822_catalepsy | 1.12376251 |
| 87 | MP0005646_abnormal_pituitary_gland | 1.11509650 |
| 88 | MP0010155_abnormal_intestine_physiology | 1.11269610 |
| 89 | MP0005275_abnormal_skin_tensile | 1.10865441 |
| 90 | * MP0002118_abnormal_lipid_homeostasis | 1.10313031 |
| 91 | MP0003633_abnormal_nervous_system | 1.09706263 |
| 92 | MP0005310_abnormal_salivary_gland | 1.08575244 |
| 93 | MP0002876_abnormal_thyroid_physiology | 1.08095037 |
| 94 | MP0003690_abnormal_glial_cell | 1.07332623 |
| 95 | MP0005535_abnormal_body_temperature | 1.07190837 |
| 96 | MP0002837_dystrophic_cardiac_calcinosis | 1.06123918 |
| 97 | MP0003879_abnormal_hair_cell | 1.06046676 |
| 98 | MP0002060_abnormal_skin_morphology | 1.04709202 |
| 99 | MP0002998_abnormal_bone_remodeling | 1.04215651 |
| 100 | MP0005332_abnormal_amino_acid | 1.03585848 |
| 101 | * MP0002229_neurodegeneration | 1.03444731 |
| 102 | MP0002006_tumorigenesis | 1.02841803 |
| 103 | MP0002184_abnormal_innervation | 1.02818372 |
| 104 | * MP0002419_abnormal_innate_immunity | 1.01632351 |
| 105 | * MP0000689_abnormal_spleen_morphology | 1.01154306 |
| 106 | * MP0002722_abnormal_immune_system | 0.98459600 |
| 107 | MP0008961_abnormal_basal_metabolism | 0.97892811 |
| 108 | MP0000604_amyloidosis | 0.96385597 |
| 109 | MP0001666_abnormal_nutrient_absorption | 0.96129328 |
| 110 | * MP0002557_abnormal_social/conspecific_i | 0.96102135 |
| 111 | MP0010386_abnormal_urinary_bladder | 0.93861842 |
| 112 | MP0003045_fibrosis | 0.93406086 |
| 113 | MP0004130_abnormal_muscle_cell | 0.92848854 |
| 114 | MP0001881_abnormal_mammary_gland | 0.92277084 |
| 115 | MP0005386_behavior/neurological_phenoty | 0.92073845 |
| 116 | MP0004924_abnormal_behavior | 0.92073845 |
| 117 | MP0003787_abnormal_imprinting | 0.91770748 |
| 118 | MP0000427_abnormal_hair_cycle | 0.91223761 |
| 119 | MP0005195_abnormal_posterior_eye | 0.90294240 |
| 120 | MP0001853_heart_inflammation | 0.89030322 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.86743315 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.85995070 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.85348477 |
| 124 | MP0008874_decreased_physiological_sensi | 0.84997492 |
| 125 | MP0004742_abnormal_vestibular_system | 0.84210332 |
| 126 | MP0004036_abnormal_muscle_relaxation | 0.83673473 |
| 127 | MP0000579_abnormal_nail_morphology | 0.83530176 |
| 128 | MP0001177_atelectasis | 0.83230799 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.83148941 |
| 130 | MP0004142_abnormal_muscle_tone | 0.81483338 |
| 131 | MP0003950_abnormal_plasma_membrane | 0.81041968 |
| 132 | MP0003828_pulmonary_edema | 0.80072859 |
| 133 | MP0004947_skin_inflammation | 0.80039993 |
| 134 | MP0000609_abnormal_liver_physiology | 0.78365616 |
| 135 | MP0005501_abnormal_skin_physiology | 0.78288701 |
| 136 | MP0002138_abnormal_hepatobiliary_system | 0.78280100 |
| 137 | MP0004215_abnormal_myocardial_fiber | 0.76976855 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.76778274 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.76309222 |
| 140 | MP0001851_eye_inflammation | 0.75168334 |
| 141 | MP0001533_abnormal_skeleton_physiology | 0.74201891 |
| 142 | MP0002148_abnormal_hypersensitivity_rea | 0.73121503 |
| 143 | MP0005379_endocrine/exocrine_gland_phen | 0.71954095 |
| 144 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71233076 |
| 145 | MP0004043_abnormal_pH_regulation | 0.71190775 |
| 146 | MP0003631_nervous_system_phenotype | 0.71067752 |
| 147 | MP0002066_abnormal_motor_capabilities/c | 0.69495099 |
| 148 | MP0003191_abnormal_cellular_cholesterol | 0.69366970 |
| 149 | MP0002095_abnormal_skin_pigmentation | 0.69221415 |
| 150 | MP0003300_gastrointestinal_ulcer | 0.68804125 |
| 151 | MP0010771_integument_phenotype | 0.68380421 |
| 152 | MP0002971_abnormal_brown_adipose | 0.68249285 |
| 153 | MP0004484_altered_response_of | 0.66995654 |
| 154 | MP0002429_abnormal_blood_cell | 0.66754938 |
| 155 | MP0002078_abnormal_glucose_homeostasis | 0.66139383 |
| 156 | MP0002736_abnormal_nociception_after | 0.65872543 |
| 157 | MP0001970_abnormal_pain_threshold | 0.65532302 |
| 158 | * MP0005620_abnormal_muscle_contractility | 0.65381012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 5.95749549 |
| 2 | T lymphocytopenia (HP:0005403) | 5.15792380 |
| 3 | Abnormality of T cell number (HP:0011839) | 5.00577073 |
| 4 | Focal motor seizures (HP:0011153) | 4.65700194 |
| 5 | Stomatitis (HP:0010280) | 4.62801799 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.39403961 |
| 7 | Abnormality of secondary sexual hair (HP:0009888) | 4.28727574 |
| 8 | Abnormality of the axillary hair (HP:0100134) | 4.28727574 |
| 9 | Increased IgE level (HP:0003212) | 4.12390041 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.00327005 |
| 11 | Abnormality of macular pigmentation (HP:0008002) | 3.97778775 |
| 12 | Febrile seizures (HP:0002373) | 3.71154356 |
| 13 | Atonic seizures (HP:0010819) | 3.63104625 |
| 14 | Dysdiadochokinesis (HP:0002075) | 3.57205820 |
| 15 | Absence seizures (HP:0002121) | 3.53905863 |
| 16 | Pigmentary retinal degeneration (HP:0001146) | 3.50013576 |
| 17 | Central scotoma (HP:0000603) | 3.41869429 |
| 18 | Abnormality of T cells (HP:0002843) | 3.30427140 |
| 19 | Scanning speech (HP:0002168) | 3.29209645 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.21066581 |
| 21 | Pustule (HP:0200039) | 3.14954148 |
| 22 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.14516005 |
| 23 | IgG deficiency (HP:0004315) | 3.11904680 |
| 24 | Hyperventilation (HP:0002883) | 3.10715569 |
| 25 | Dysmetric saccades (HP:0000641) | 3.08242064 |
| 26 | Autoimmune hemolytic anemia (HP:0001890) | 3.07572008 |
| 27 | Xanthomatosis (HP:0000991) | 3.07250050 |
| 28 | Deep venous thrombosis (HP:0002625) | 2.98632682 |
| 29 | Focal seizures (HP:0007359) | 2.98325237 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 2.98286205 |
| 31 | Action tremor (HP:0002345) | 2.95602350 |
| 32 | Exercise-induced myalgia (HP:0003738) | 2.95438524 |
| 33 | Visual hallucinations (HP:0002367) | 2.92874405 |
| 34 | Papilledema (HP:0001085) | 2.90741513 |
| 35 | Intrahepatic cholestasis (HP:0001406) | 2.90184698 |
| 36 | Chorioretinal atrophy (HP:0000533) | 2.89064434 |
| 37 | Decreased central vision (HP:0007663) | 2.87391338 |
| 38 | Dialeptic seizures (HP:0011146) | 2.83186522 |
| 39 | Genetic anticipation (HP:0003743) | 2.82773065 |
| 40 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.79385516 |
| 41 | Gaze-evoked nystagmus (HP:0000640) | 2.79179596 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.76517704 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.75356330 |
| 44 | Optic neuritis (HP:0100653) | 2.75356330 |
| 45 | Hypotrichosis (HP:0001006) | 2.73375530 |
| 46 | Stomach cancer (HP:0012126) | 2.71811631 |
| 47 | Status epilepticus (HP:0002133) | 2.71091420 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69903853 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69903853 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.69010848 |
| 51 | Hemiplegia (HP:0002301) | 2.67311746 |
| 52 | Myositis (HP:0100614) | 2.65620400 |
| 53 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.65313205 |
| 54 | Prolonged partial thromboplastin time (HP:0003645) | 2.64342774 |
| 55 | Generalized tonic-clonic seizures (HP:0002069) | 2.60885112 |
| 56 | Joint swelling (HP:0001386) | 2.59372836 |
| 57 | Intention tremor (HP:0002080) | 2.58968151 |
| 58 | Severe combined immunodeficiency (HP:0004430) | 2.56488518 |
| 59 | Recurrent bronchitis (HP:0002837) | 2.56216900 |
| 60 | Hypoalphalipoproteinemia (HP:0003233) | 2.54143986 |
| 61 | Hyperkalemia (HP:0002153) | 2.53414052 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.52982048 |
| 63 | Scotoma (HP:0000575) | 2.52346607 |
| 64 | Erythroderma (HP:0001019) | 2.52276633 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.51874778 |
| 66 | Recurrent skin infections (HP:0001581) | 2.50702871 |
| 67 | Abnormality of eosinophils (HP:0001879) | 2.49208517 |
| 68 | Generalized hypopigmentation of hair (HP:0011358) | 2.41760590 |
| 69 | Hyporeflexia of lower limbs (HP:0002600) | 2.40778644 |
| 70 | Thyroiditis (HP:0100646) | 2.39957054 |
| 71 | Truncal ataxia (HP:0002078) | 2.37873637 |
| 72 | Ketoacidosis (HP:0001993) | 2.37342510 |
| 73 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.37336925 |
| 74 | Dyschromatopsia (HP:0007641) | 2.36615211 |
| 75 | Diplopia (HP:0000651) | 2.35654031 |
| 76 | Abnormality of binocular vision (HP:0011514) | 2.35654031 |
| 77 | Chronic diarrhea (HP:0002028) | 2.30258935 |
| 78 | Complement deficiency (HP:0004431) | 2.30251204 |
| 79 | Ketosis (HP:0001946) | 2.29270334 |
| 80 | Abnormality of the common coagulation pathway (HP:0010990) | 2.27641307 |
| 81 | Orchitis (HP:0100796) | 2.27258730 |
| 82 | Broad-based gait (HP:0002136) | 2.25374060 |
| 83 | Macular degeneration (HP:0000608) | 2.25294037 |
| 84 | Erythema (HP:0010783) | 2.24924527 |
| 85 | Abnormality of incisor morphology (HP:0011063) | 2.23857316 |
| 86 | Keratoconjunctivitis sicca (HP:0001097) | 2.22488314 |
| 87 | Abnormality of T cell physiology (HP:0011840) | 2.22299110 |
| 88 | Parakeratosis (HP:0001036) | 2.21819201 |
| 89 | Hemiparesis (HP:0001269) | 2.21097666 |
| 90 | Decreased circulating renin level (HP:0003351) | 2.20644735 |
| 91 | Dysmetria (HP:0001310) | 2.20537964 |
| 92 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.17360015 |
| 93 | Abnormality of the columella (HP:0009929) | 2.14350748 |
| 94 | Palmoplantar hyperkeratosis (HP:0000972) | 2.13352045 |
| 95 | Epidermoid cyst (HP:0200040) | 2.12146380 |
| 96 | Hemoptysis (HP:0002105) | 2.08597457 |
| 97 | Eosinophilia (HP:0001880) | 2.08528416 |
| 98 | Pulmonary infiltrates (HP:0002113) | 2.07763600 |
| 99 | Increased IgM level (HP:0003496) | 2.07512348 |
| 100 | Conjunctival hamartoma (HP:0100780) | 2.05610394 |
| 101 | Vasculitis (HP:0002633) | 2.05138568 |
| 102 | Palmar hyperkeratosis (HP:0010765) | 2.04418409 |
| 103 | Corneal erosion (HP:0200020) | 2.04117452 |
| 104 | Gangrene (HP:0100758) | 2.03361667 |
| 105 | Attenuation of retinal blood vessels (HP:0007843) | 2.02119254 |
| 106 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01072769 |
| 107 | Recurrent bacterial skin infections (HP:0005406) | 2.00036978 |
| 108 | Hypolipoproteinemia (HP:0010981) | 2.00021903 |
| 109 | Widely spaced teeth (HP:0000687) | 1.99806673 |
| 110 | Keratoconjunctivitis (HP:0001096) | 1.98508537 |
| 111 | Leukocytosis (HP:0001974) | 1.98412293 |
| 112 | Blue irides (HP:0000635) | 1.97165254 |
| 113 | Tetraplegia (HP:0002445) | 1.96861193 |
| 114 | Mitral stenosis (HP:0001718) | 1.94444227 |
| 115 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.91159642 |
| 116 | Hypergammaglobulinemia (HP:0010702) | 1.89265426 |
| 117 | Cone-rod dystrophy (HP:0000548) | 1.88811621 |
| 118 | Photophobia (HP:0000613) | 1.88669776 |
| 119 | Skin nodule (HP:0200036) | 1.88302387 |
| 120 | Anxiety (HP:0000739) | 1.87438067 |
| 121 | Impaired smooth pursuit (HP:0007772) | 1.87250048 |
| 122 | Muscle fiber inclusion bodies (HP:0100299) | 1.87093758 |
| 123 | Impaired social interactions (HP:0000735) | 1.86667397 |
| 124 | Abnormal social behavior (HP:0012433) | 1.86667397 |
| 125 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.85881006 |
| 126 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85745093 |
| 127 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.85606198 |
| 128 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.84376956 |
| 129 | Nemaline bodies (HP:0003798) | 1.82784395 |
| 130 | Hematochezia (HP:0002573) | 1.79709240 |
| 131 | Conjugated hyperbilirubinemia (HP:0002908) | 1.77262602 |
| 132 | Verrucae (HP:0200043) | 1.77222801 |
| 133 | Papilloma (HP:0012740) | 1.77222801 |
| 134 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.76929751 |
| 135 | Abnormality of saccadic eye movements (HP:0000570) | 1.75156682 |
| 136 | Generalized myoclonic seizures (HP:0002123) | 1.74993090 |
| 137 | Neurofibrillary tangles (HP:0002185) | 1.74714877 |
| 138 | Alopecia of scalp (HP:0002293) | 1.74489513 |
| 139 | Areflexia of lower limbs (HP:0002522) | 1.73746895 |
| 140 | Encephalitis (HP:0002383) | 1.72952446 |
| 141 | Agitation (HP:0000713) | 1.72084964 |
| 142 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.71941234 |
| 143 | Aplasia of the phalanges of the hand (HP:0009802) | 1.71941234 |
| 144 | Aplasia involving bones of the extremities (HP:0009825) | 1.71941234 |
| 145 | Depression (HP:0000716) | 1.71474751 |
| 146 | Fair hair (HP:0002286) | 1.71473830 |
| 147 | Severe Myopia (HP:0011003) | 1.71456206 |
| 148 | Drooling (HP:0002307) | 1.71266273 |
| 149 | Excessive salivation (HP:0003781) | 1.71266273 |
| 150 | EEG with generalized epileptiform discharges (HP:0011198) | 1.70369113 |
| 151 | Pulmonary embolism (HP:0002204) | 1.69915019 |
| 152 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.69611948 |
| 153 | Conical tooth (HP:0000698) | 1.69452181 |
| 154 | Hypobetalipoproteinemia (HP:0003563) | 1.69072754 |
| 155 | Synostosis involving the elbow (HP:0003938) | 1.69021795 |
| 156 | Humeroradial synostosis (HP:0003041) | 1.69021795 |
| 157 | Myokymia (HP:0002411) | 1.68649744 |
| 158 | Epileptiform EEG discharges (HP:0011182) | 1.68599904 |
| 159 | Thick nail (HP:0001805) | 1.68017005 |
| 160 | Anhidrosis (HP:0000970) | 1.67743292 |
| 161 | Autoimmune thrombocytopenia (HP:0001973) | 1.66424658 |
| 162 | Poor eye contact (HP:0000817) | 1.66357649 |
| 163 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.65356928 |
| 164 | Gingival bleeding (HP:0000225) | 1.65203212 |
| 165 | Atrioventricular block (HP:0001678) | 1.64946963 |
| 166 | Increased corneal curvature (HP:0100692) | 1.62231477 |
| 167 | Keratoconus (HP:0000563) | 1.62231477 |
| 168 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.61769437 |
| 169 | Vitreoretinal degeneration (HP:0000655) | 1.60160950 |
| 170 | Abnormality of vision evoked potentials (HP:0000649) | 1.59838570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 2.91301057 |
| 2 | TXK | 2.87475709 |
| 3 | INSRR | 2.32716771 |
| 4 | MAP4K1 | 2.23508998 |
| 5 | MAP2K4 | 2.21647824 |
| 6 | NLK | 2.14610480 |
| 7 | STK24 | 2.13227010 |
| 8 | MAP3K4 | 2.01524119 |
| 9 | SIK1 | 1.87983845 |
| 10 | AKT3 | 1.75939148 |
| 11 | CASK | 1.67439836 |
| 12 | NTRK3 | 1.64024682 |
| 13 | MAP3K7 | 1.61833977 |
| 14 | CAMKK2 | 1.60591154 |
| 15 | MAP2K7 | 1.57210592 |
| 16 | JAK1 | 1.55276154 |
| 17 | MAPK15 | 1.55218095 |
| 18 | RIPK1 | 1.50621163 |
| 19 | GRK6 | 1.48487386 |
| 20 | IRAK3 | 1.46221007 |
| 21 | NTRK2 | 1.44588224 |
| 22 | MAP3K9 | 1.44151822 |
| 23 | CAMK1G | 1.42011276 |
| 24 | TYK2 | 1.41207369 |
| 25 | SGK2 | 1.40366931 |
| 26 | STK38 | 1.39020042 |
| 27 | EPHA4 | 1.37697245 |
| 28 | TRPM7 | 1.34809119 |
| 29 | EPHA3 | 1.32800125 |
| 30 | CSK | 1.30455663 |
| 31 | DAPK2 | 1.30066620 |
| 32 | FER | 1.29747782 |
| 33 | TEC | 1.25269369 |
| 34 | FRK | 1.23621380 |
| 35 | FGFR3 | 1.23503270 |
| 36 | SGK3 | 1.21621028 |
| 37 | PNCK | 1.17651810 |
| 38 | SGK494 | 1.16170407 |
| 39 | SGK223 | 1.16170407 |
| 40 | GRK1 | 1.15871508 |
| 41 | MAP3K2 | 1.15512827 |
| 42 | TNIK | 1.14450132 |
| 43 | LCK | 1.14179833 |
| 44 | FGFR4 | 1.12203241 |
| 45 | PINK1 | 1.11833675 |
| 46 | ITK | 1.08436826 |
| 47 | BTK | 1.07679327 |
| 48 | SYK | 1.07125404 |
| 49 | MINK1 | 1.05962348 |
| 50 | PAK6 | 1.03393581 |
| 51 | FGFR2 | 1.02955703 |
| 52 | ZAP70 | 1.02276392 |
| 53 | PHKG1 | 1.02262294 |
| 54 | PHKG2 | 1.02262294 |
| 55 | MAPK12 | 1.02191333 |
| 56 | CAMKK1 | 1.02142332 |
| 57 | CDK3 | 1.01622561 |
| 58 | MARK3 | 1.01093506 |
| 59 | TNK2 | 1.00959214 |
| 60 | STK11 | 0.96742199 |
| 61 | HIPK2 | 0.96141110 |
| 62 | SIK2 | 0.94415170 |
| 63 | IKBKB | 0.93920333 |
| 64 | WNK1 | 0.93891200 |
| 65 | MAP3K12 | 0.93566932 |
| 66 | PRKCH | 0.92670494 |
| 67 | BRD4 | 0.90292935 |
| 68 | RIPK4 | 0.90287237 |
| 69 | GRK5 | 0.88833478 |
| 70 | MAPKAPK5 | 0.88775644 |
| 71 | MAP3K14 | 0.87276319 |
| 72 | NTRK1 | 0.86806078 |
| 73 | MAP3K13 | 0.86349860 |
| 74 | MAPK7 | 0.85885965 |
| 75 | MAP3K6 | 0.85169837 |
| 76 | BLK | 0.84801919 |
| 77 | JAK3 | 0.84403062 |
| 78 | RET | 0.83436878 |
| 79 | HCK | 0.80629921 |
| 80 | PASK | 0.80146316 |
| 81 | PIM1 | 0.78957620 |
| 82 | JAK2 | 0.78280081 |
| 83 | TGFBR2 | 0.77329698 |
| 84 | PIK3CG | 0.76563059 |
| 85 | PTK6 | 0.76121986 |
| 86 | CAMK2G | 0.76098240 |
| 87 | CDK5 | 0.73783794 |
| 88 | CAMK2A | 0.73627672 |
| 89 | LATS1 | 0.73440975 |
| 90 | MST1R | 0.73414051 |
| 91 | MELK | 0.72813732 |
| 92 | CAMK1 | 0.71040293 |
| 93 | PDK1 | 0.69250717 |
| 94 | SIK3 | 0.68709852 |
| 95 | NEK6 | 0.68277059 |
| 96 | CAMK2D | 0.67974305 |
| 97 | MAP2K6 | 0.67961676 |
| 98 | FES | 0.67823694 |
| 99 | SGK1 | 0.67002694 |
| 100 | CAMK1D | 0.66956586 |
| 101 | PRKCG | 0.66641532 |
| 102 | PRKCE | 0.66597917 |
| 103 | ERBB4 | 0.65723882 |
| 104 | PRKAA2 | 0.64684770 |
| 105 | MUSK | 0.63633550 |
| 106 | MAP3K1 | 0.62798723 |
| 107 | PAK3 | 0.60969591 |
| 108 | DYRK1A | 0.60854319 |
| 109 | BMPR2 | 0.60604398 |
| 110 | PKN1 | 0.59755609 |
| 111 | GRK7 | 0.57504793 |
| 112 | LYN | 0.55734217 |
| 113 | PRKG1 | 0.55634684 |
| 114 | MAPKAPK3 | 0.55386419 |
| 115 | PDGFRB | 0.55384777 |
| 116 | PRKCZ | 0.54892691 |
| 117 | IRAK1 | 0.54209431 |
| 118 | RPS6KB1 | 0.54113540 |
| 119 | PIK3CA | 0.53923009 |
| 120 | EPHB1 | 0.53690909 |
| 121 | PDPK1 | 0.53682058 |
| 122 | TGFBR1 | 0.53411690 |
| 123 | DMPK | 0.52829528 |
| 124 | CAMK4 | 0.52780713 |
| 125 | PRKAA1 | 0.51478031 |
| 126 | OBSCN | 0.51434181 |
| 127 | STK10 | 0.50276512 |
| 128 | MARK2 | 0.49665142 |
| 129 | PRPF4B | 0.49653834 |
| 130 | ADRBK2 | 0.49598522 |
| 131 | KIT | 0.48714937 |
| 132 | RPS6KA3 | 0.48423590 |
| 133 | PRKCQ | 0.48189333 |
| 134 | FGFR1 | 0.47915846 |
| 135 | IKBKE | 0.47835022 |
| 136 | MAPK11 | 0.47553994 |
| 137 | TYRO3 | 0.47242806 |
| 138 | MOS | 0.45187902 |
| 139 | KSR2 | 0.44804840 |
| 140 | FYN | 0.44397334 |
| 141 | MAP3K3 | 0.43477796 |
| 142 | FGR | 0.42451290 |
| 143 | CHUK | 0.40555081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.05096632 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.79980852 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.76088406 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.65264272 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.53164374 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.13480564 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09099753 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.99685135 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.97780034 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92654601 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.85836785 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.84248397 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.68896111 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.68810227 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.62106028 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.55429501 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54735922 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.54017635 |
| 19 | * Circadian rhythm_Homo sapiens_hsa04710 | 1.53504456 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.53009224 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51407521 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39441175 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38354863 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.37576101 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.35548185 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.32600277 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.32562173 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.30617929 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.28331889 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.27178811 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.27134419 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25935237 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25472244 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.25448280 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.24466846 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23508502 |
| 37 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.21103379 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20031075 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 1.19670694 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.19098442 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15811303 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.11116430 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10864134 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10671493 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08446289 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08208532 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05656457 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05261859 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03289610 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.02308548 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01038773 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.00465004 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00249504 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00069057 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.99967407 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99536003 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.99519109 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98225901 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98080571 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.97855871 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96473167 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96063736 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94707494 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94074084 |
| 65 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93992247 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92709592 |
| 67 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92077527 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90982625 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90215798 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89971508 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89679879 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88702046 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86072414 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85865306 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.85397555 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84578060 |
| 77 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84551292 |
| 78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83946321 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83926184 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83278504 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82314674 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78765491 |
| 83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78039108 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76738314 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.76284562 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74640777 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72965566 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72867852 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.71013706 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70982369 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70690661 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70659733 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69834926 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69497363 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68645948 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.67953277 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67664882 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66689518 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66578584 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66054242 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65846809 |
| 102 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64963752 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.64258521 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63356403 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62809755 |
| 106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62747793 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62310976 |
| 108 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61913323 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61791214 |
| 110 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61724583 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61170210 |
| 112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60608938 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60597474 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58643273 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58483811 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57215875 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.56827078 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56751678 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56538879 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56140235 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55228968 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55207612 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55054761 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54952556 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54822961 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53380911 |
| 127 | Histidine metabolism_Homo sapiens_hsa00340 | 0.53018018 |
| 128 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53010587 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51806851 |
| 130 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51464754 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51090058 |
| 132 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50256910 |
| 133 | Glioma_Homo sapiens_hsa05214 | 0.48846700 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48252717 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48128748 |
| 136 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42703262 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42215530 |
| 138 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41973194 |
| 139 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41926225 |
| 140 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41572384 |
| 141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41300827 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41005143 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39284220 |
| 144 | Melanogenesis_Homo sapiens_hsa04916 | 0.37931781 |
| 145 | Gap junction_Homo sapiens_hsa04540 | 0.37764167 |
| 146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36311065 |
| 147 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35306754 |
| 148 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34623202 |

